Prolonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia & lymphoma 2008-04, Vol.49 (4), p.815-816
Hauptverfasser:	Saulnier, Pierre-Jean, Dalbiès, Florence, Berthou, Christian, Guilhot, François, Bourmeyster, Nicolas, Chomel, Jean-claude, Thuran, Ali
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Benzamides Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Male Middle Aged Piperazines - therapeutic use Pyrimidines - therapeutic use Remission Induction - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	816
container_issue	4
container_start_page	815
container_title	Leukemia & lymphoma
container_volume	49
creator	Saulnier, Pierre-Jean Dalbiès, Florence Berthou, Christian Guilhot, François Bourmeyster, Nicolas Chomel, Jean-claude Thuran, Ali
description
doi_str_mv	10.1080/10428190801930514
format	Article
fullrecord	<record><control><sourceid>pubmed_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_1080_10428190801930514</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18398751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c325t-75e6c84eb2f9b4a0b7be5b5d679c417bf6570fe3c9e46d88bc460f7c0639b3983</originalsourceid><addsrcrecordid>eNp9kEtrGzEUhUVoiB0nPyCboj8wjTSjeYh0U0z6AEO6SNaDHlceORrJSDMt3veHR8aBEgJZ3QP3fId7D0I3lHyhpCO3lLCyozxLyitSU3aGlpSUvCgZqT4dNSuLbGALdJnSjhBS86a8QAvaVbxra7pE_37H4ILfgsZjcKBmJyKOMNqUbPDYeiz0H-FV3u8HkQAHg9UQg7cKjwdwwWrsYH7OhMBzsn6LVRil9WI68tltxyy9lVh4jQe7HQodco4aYAzTAFHsD1fo3AiX4Pp1rtDT9_vH9c9i8_Dj1_rbplBVWU9FW0OjOgayNFwyQWQroZa1blquGG2laeqWGKgUB9borpOKNcS0ijQVl_nhaoXoKVfFkFIE0-9jPi8eekr6Y6P9u0Yz8_nE7Gc5gv5PvFaYDV9PButNiKP4G6LT_SQOLkQTc3U29dVH-Xdv8AGEmwYlIvS7MEef-_jguheHa5l2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prolonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy</title><source>Taylor & Francis</source><source>MEDLINE</source><source>Taylor & Francis Medical Library - CRKN</source><creator>Saulnier, Pierre-Jean ; Dalbiès, Florence ; Berthou, Christian ; Guilhot, François ; Bourmeyster, Nicolas ; Chomel, Jean-claude ; Thuran, Ali</creator><creatorcontrib>Saulnier, Pierre-Jean ; Dalbiès, Florence ; Berthou, Christian ; Guilhot, François ; Bourmeyster, Nicolas ; Chomel, Jean-claude ; Thuran, Ali</creatorcontrib><identifier>ISSN: 1042-8194</identifier><identifier>EISSN: 1029-2403</identifier><identifier>DOI: 10.1080/10428190801930514</identifier><identifier>PMID: 18398751</identifier><language>eng</language><publisher>United States: Informa UK Ltd</publisher><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Benzamides ; Humans ; Imatinib Mesylate ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy ; Male ; Middle Aged ; Piperazines - therapeutic use ; Pyrimidines - therapeutic use ; Remission Induction - methods</subject><ispartof>Leukemia & lymphoma, 2008-04, Vol.49 (4), p.815-816</ispartof><rights>2008 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c325t-75e6c84eb2f9b4a0b7be5b5d679c417bf6570fe3c9e46d88bc460f7c0639b3983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/10428190801930514$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/10428190801930514$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,59620,59726,60409,60515,61194,61229,61375,61410</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18398751$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saulnier, Pierre-Jean</creatorcontrib><creatorcontrib>Dalbiès, Florence</creatorcontrib><creatorcontrib>Berthou, Christian</creatorcontrib><creatorcontrib>Guilhot, François</creatorcontrib><creatorcontrib>Bourmeyster, Nicolas</creatorcontrib><creatorcontrib>Chomel, Jean-claude</creatorcontrib><creatorcontrib>Thuran, Ali</creatorcontrib><title>Prolonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy</title><title>Leukemia & lymphoma</title><addtitle>Leuk Lymphoma</addtitle><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Benzamides</subject><subject>Humans</subject><subject>Imatinib Mesylate</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Piperazines - therapeutic use</subject><subject>Pyrimidines - therapeutic use</subject><subject>Remission Induction - methods</subject><issn>1042-8194</issn><issn>1029-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtrGzEUhUVoiB0nPyCboj8wjTSjeYh0U0z6AEO6SNaDHlceORrJSDMt3veHR8aBEgJZ3QP3fId7D0I3lHyhpCO3lLCyozxLyitSU3aGlpSUvCgZqT4dNSuLbGALdJnSjhBS86a8QAvaVbxra7pE_37H4ILfgsZjcKBmJyKOMNqUbPDYeiz0H-FV3u8HkQAHg9UQg7cKjwdwwWrsYH7OhMBzsn6LVRil9WI68tltxyy9lVh4jQe7HQodco4aYAzTAFHsD1fo3AiX4Pp1rtDT9_vH9c9i8_Dj1_rbplBVWU9FW0OjOgayNFwyQWQroZa1blquGG2laeqWGKgUB9borpOKNcS0ijQVl_nhaoXoKVfFkFIE0-9jPi8eekr6Y6P9u0Yz8_nE7Gc5gv5PvFaYDV9PButNiKP4G6LT_SQOLkQTc3U29dVH-Xdv8AGEmwYlIvS7MEef-_jguheHa5l2</recordid><startdate>20080401</startdate><enddate>20080401</enddate><creator>Saulnier, Pierre-Jean</creator><creator>Dalbiès, Florence</creator><creator>Berthou, Christian</creator><creator>Guilhot, François</creator><creator>Bourmeyster, Nicolas</creator><creator>Chomel, Jean-claude</creator><creator>Thuran, Ali</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20080401</creationdate><title>Prolonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy</title><author>Saulnier, Pierre-Jean ; Dalbiès, Florence ; Berthou, Christian ; Guilhot, François ; Bourmeyster, Nicolas ; Chomel, Jean-claude ; Thuran, Ali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c325t-75e6c84eb2f9b4a0b7be5b5d679c417bf6570fe3c9e46d88bc460f7c0639b3983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Benzamides</topic><topic>Humans</topic><topic>Imatinib Mesylate</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Piperazines - therapeutic use</topic><topic>Pyrimidines - therapeutic use</topic><topic>Remission Induction - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saulnier, Pierre-Jean</creatorcontrib><creatorcontrib>Dalbiès, Florence</creatorcontrib><creatorcontrib>Berthou, Christian</creatorcontrib><creatorcontrib>Guilhot, François</creatorcontrib><creatorcontrib>Bourmeyster, Nicolas</creatorcontrib><creatorcontrib>Chomel, Jean-claude</creatorcontrib><creatorcontrib>Thuran, Ali</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Leukemia & lymphoma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saulnier, Pierre-Jean</au><au>Dalbiès, Florence</au><au>Berthou, Christian</au><au>Guilhot, François</au><au>Bourmeyster, Nicolas</au><au>Chomel, Jean-claude</au><au>Thuran, Ali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy</atitle><jtitle>Leukemia & lymphoma</jtitle><addtitle>Leuk Lymphoma</addtitle><date>2008-04-01</date><risdate>2008</risdate><volume>49</volume><issue>4</issue><spage>815</spage><epage>816</epage><pages>815-816</pages><issn>1042-8194</issn><eissn>1029-2403</eissn><cop>United States</cop><pub>Informa UK Ltd</pub><pmid>18398751</pmid><doi>10.1080/10428190801930514</doi><tpages>2</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1042-8194
ispartof	Leukemia & lymphoma, 2008-04, Vol.49 (4), p.815-816
issn	1042-8194 1029-2403
language	eng
recordid	cdi_informahealthcare_journals_10_1080_10428190801930514
source	Taylor & Francis; MEDLINE; Taylor & Francis Medical Library - CRKN
subjects	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Benzamides Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Male Middle Aged Piperazines - therapeutic use Pyrimidines - therapeutic use Remission Induction - methods
title	Prolonged molecular remission in advanced phase of chronic myeloid leukemia using combination of imatinib and high-dose chemotherapy
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A08%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolonged%20molecular%20remission%20in%20advanced%20phase%20of%20chronic%20myeloid%20leukemia%20using%20combination%20of%20imatinib%20and%20high-dose%20chemotherapy&rft.jtitle=Leukemia%20&%20lymphoma&rft.au=Saulnier,%20Pierre-Jean&rft.date=2008-04-01&rft.volume=49&rft.issue=4&rft.spage=815&rft.epage=816&rft.pages=815-816&rft.issn=1042-8194&rft.eissn=1029-2403&rft_id=info:doi/10.1080/10428190801930514&rft_dat=%3Cpubmed_infor%3E18398751%3C/pubmed_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/18398751&rfr_iscdi=true